Kategorien
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
(1S)-(+)-Camphor-10-sulfonic acid
(36619497 | 3144-16-9)
CAS: | 3144-16-9 |
---|---|
Molekularformel: | C10H16O4S |
Molekulargewicht: | 232.30 |
Verfügbarkeit: | Auf Lager |
---|---|
Downloads: | | |
Für dieses Produkt wird ein Gefahrstoffzuschlag erhoben. Der genaue Betrag wird von unserem Verkaufsteam bestätigt.
36619497-100g | 100g | £30.90 | |
Bulk Menge |
36619497-100g | 100g | €43.30 | |
Bulk Menge |
36619497-100g | 100g | $46.40 | |
Bulk Menge |
Sicherheitsdatenblatt
Analysezertifikat
Produktbeschreibung
Product Code | 36619497 | ||||
Product Name | (1S)-(+)-Camphor-10-sulfonic acid | ||||
Categories | Biochemicals Building Blocks Chiral Compounds Organics Peptide Reagents | ||||
CAS | 3144-16-9 | ||||
Molecular Formula | C10H16O4S | ||||
Molecular Weight | 232.30 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 2914710000 |
Produktspezifikation
Melting Point | 193 - 202 Deg C | ||||
Specific rotation | +21° to +23° | ||||
Loss on Drying | 1.0% max | ||||
Assay | 99% min | ||||
Appearance | Almost white crystalline powder |
Sicherheitsinformation
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|